A Urine Paper Titled ‘THC Quantification’ Actually Targeted THC-COOH
The analyte in a laboratory method matters more than shorthand in its title. A paper titled as urinary THC quantification describes a confirmatory method for THC-COOH, the carboxy metabolite. That is not a measurement of active parent THC or contemporaneous impairment.
What the method measured
The investigators developed solid-phase extraction followed by gas chromatography–mass spectrometry for urine specimens. The preparation addressed conjugated metabolite through hydrolysis before measurement.
Its reported calibration range was 15 to 300 ng/mL. The study also described precision and recovery, then applied the method to a clinical sample series. Those performance measures concern analytical quantification of the specified metabolite.
Why the name changes the inference
THC-COOH and THC are chemically and pharmacologically distinct. A numerical metabolite result cannot be relabeled as a parent-THC concentration simply because the paper’s heading uses the broader term THC.
Hydrolysis also affects what is counted. Measuring total metabolite after releasing conjugated material is a different analytical question from measuring unconjugated compound alone. Comparisons require the same analyte definition and preparation.
The limitation the authors acknowledged
The paper explicitly stated that its approach could not distinguish acute from chronic cannabis use. That admission prevents the assay’s precision from being turned into a validated recent-use classifier.
Nor did the clinical application establish a cutoff for driving impairment. The number of cannabinoid-positive specimens in a selected testing series cannot estimate community prevalence without an appropriate sampling design.
In reviewing a urine report, identify the reference standard, hydrolysis, confirmation criteria, calibration range and reporting units before asking what the result means. Reliable measurement and valid behavioral interpretation remain separate requirements.
Related analysis
See our analysis of why a cannabinoid concentration does not independently establish impairment.
Primary research
Priyamvada Sharma and colleagues. Quantification of Δ9-tetrahydrocannabinol in urine as a marker of cannabis abuse. The Indian Journal of Medical Research. DOI: 10.4103/ijmr.IJMR_3899_20.
